XML 82 R71.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Operating Segments (Schedule Of Segment Reporting Information By Segment) (Details) (USD $)
In Millions
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Segment Reporting Information [Line Items]        
Net sales $ 2,005 $ 1,712 $ 3,928 $ 3,265
Research, development and engineering expenses 172 144 328 289
Restructuring, impairment and other credits       (2)
Equity in earnings of affiliated companies 428 474 826 943
Display Technologies [Member]
       
Segment Reporting Information [Line Items]        
Net sales 760 834 1,550 1,616
Depreciation 123 [1] 129 [1] 247 [1] 257 [1]
Research, development and engineering expenses 27 [2] 21 [2] 52 [2] 44 [2]
Equity in earnings of affiliated companies 319 353 613 697
Income tax (provision) benefit (118) (151) (257) (283)
Net income (loss) 626 [3] 756 [3] 1,264 [3] 1,459 [3]
Telecommunications [Member]
       
Segment Reporting Information [Line Items]        
Net sales 548 441 1,022 805
Depreciation 32 [1] 32 [1] 60 [1] 62 [1]
Amortization of purchased intangibles 2   3 1
Research, development and engineering expenses 32 [2] 28 [2] 61 [2] 57 [2]
Equity in earnings of affiliated companies 1 1 4 1
Income tax (provision) benefit (22) (14) (41) (18)
Net income (loss) 46 [3] 30 [3] 87 [3] 38 [3]
Environmental Technologies [Member]
       
Segment Reporting Information [Line Items]        
Net sales 258 184 517 376
Depreciation 27 [1] 25 [1] 52 [1] 51 [1]
Research, development and engineering expenses 23 [2] 23 [2] 46 [2] 46 [2]
Equity in earnings of affiliated companies 1 1 1 4
Income tax (provision) benefit (15) (2) (29) (7)
Net income (loss) 32 [3] 5 [3] 61 [3] 16 [3]
Specialty Materials [Member]
       
Segment Reporting Information [Line Items]        
Net sales 283 126 537 222
Depreciation 42 [1] 12 [1] 79 [1] 23 [1]
Research, development and engineering expenses 36 [2] 20 [2] 65 [2] 36 [2]
Restructuring, impairment and other credits       (2)
Equity in earnings of affiliated companies 5   8  
Income tax (provision) benefit (9) 9 (12) 12
Net income (loss) 23 [3] (17) [3] 31 [3] (24) [3]
Life Sciences [Member]
       
Segment Reporting Information [Line Items]        
Net sales 155 125 299 243
Depreciation 9 [1] 8 [1] 17 [1] 16 [1]
Amortization of purchased intangibles 2 2 4 3
Research, development and engineering expenses 5 [2] 4 [2] 9 [2] 8 [2]
Income tax (provision) benefit (7) (9) (14) (17)
Net income (loss) 15 [3] 18 [3] 30 [3] 35 [3]
All Other [Member]
       
Segment Reporting Information [Line Items]        
Net sales 1 2 3 3
Depreciation 3 [1] 3 [1] 5 [1] 6 [1]
Research, development and engineering expenses 24 [2] 28 [2] 46 [2] 56 [2]
Equity in earnings of affiliated companies 2 5 9 16
Income tax (provision) benefit 10 13 19 24
Net income (loss) (20) [3] (19) [3] (35) [3] (34) [3]
Total [Member]
       
Segment Reporting Information [Line Items]        
Net sales 2,005 1,712 3,928 3,265
Depreciation 236 [1] 209 [1] 460 [1] 415 [1]
Amortization of purchased intangibles 4 2 7 4
Research, development and engineering expenses 147 [2] 124 [2] 279 [2] 247 [2]
Restructuring, impairment and other credits       (2)
Equity in earnings of affiliated companies 328 360 635 718
Income tax (provision) benefit (161) (154) (334) (289)
Net income (loss) $ 722 [3] $ 773 [3] $ 1,438 [3] $ 1,490 [3]
[1] Depreciation expense for Corning's reportable segments includes an allocation of depreciation of corporate property not specifically identifiable to a segment.
[2] Research, development, and engineering expenses include direct project spending that is identifiable to a segment.
[3] Many of Corning's administrative and staff functions are performed on a centralized basis. Where practicable, Corning charges these expenses to segments based upon the extent to which each business uses a centralized function. Other staff functions, such as corporate finance, human resources and legal, are allocated to segments, primarily as a percentage of sales.